Cantabria Labs eyes 800 million euros in revenue by 2030, powered by growth in Latin America and the US


The Spanish dermatology group is expected to grow by 14% in 2026, approaching revenue of 450 million euros, and has set its targets for 2030. Italian CEO Stefano Fatelli, outlines its strategies and key markets.

The Spanish dermatology group is expected to grow by 14% in 2026, approaching revenue of 450 million euros, and has set its targets for 2030. Italian CEO Stefano Fatelli, outlines its strategies and key markets.